Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Musculoskeletal discomfort, Musculoskeletal stiffness, Paraesthesia, Swelling face
Clinical narrative: Prickling/tingling; Numbness face/ neck; Feeling hot; Flushing; Inappropriate schedule of vaccine administered; Headache; Burning on the left side of the neck; burning on the left side of the ear; swelling on the left side of the face; Stiff neck on the left side side of the neck; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Burning on the left side of the neck), EAR DISCOMFORT (burning on the left side of the ear), MUSCULOSKELETAL STIFFNESS (Stiff neck on the left side side of the neck), PARAESTHESIA (Prickling/tingling) and HYPOAESTHESIA (Numbness face/ neck) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer (Cancer removed: radiation/on Letrazole) on 30-Jun-2017, Hay fever, GERD, High cholesterol and Hypothyroidism. Concurrent medical conditions included Allergy to antibiotic (Keflex), Penicillin allergy, Sulfonamide allergy and Hashimoto's disease since 01-Jan-1986. Concomitant products included LETROZOLE from 01-Jan-2017 to an unknown date for Breast cancer, OMEPRAZOLE from 01-Jan-2001 to an unknown date for GERD, LEVOTHYROXINE SODIUM (SYNTHROID) from 01-Jan-1986 to an unknown date and LIOTHYRONINE SODIUM (CYTOMEL) from 01-Jan-2001 to an unknown date for Hashimoto's disease, ROSUVASTATIN from 01-Jan-2015 to an unknown date for High cholesterol.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (Burning on the left side of the neck), EAR DISCOMFORT (burning on the left side of the ear), MUSCULOSKELETAL STIFFNESS (Stiff neck on the left side side of the neck) and HEADACHE (Headache). On an unknown date, the patient experienced PARAESTHESIA (Prickling/tingling), HYPOAESTHESIA (Numbness face/ neck), FEELING HOT (Feeling hot), FLUSHING (Flushing) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse event, at a dose of UNK decigram. At the time of the report, MUSCULOSKELETAL DISCOMFORT (Burning on the left side of the neck), EAR DISCOMFORT (burning on the left side of the ear), MUSCULOSKELETAL STIFFNESS (Stiff neck on the left side side of the neck), PARAESTHESIA (Prickling/tingling), HYPOAESTHESIA (Numbness face/ neck), FEELING HOT (Feeling hot), FLUSHING (Flushing), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and HEADACHE (Headache) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 29 Jan 2021 as well as 26 Feb 2021, the patient was seen by her PCP (primary care provider) for the adverse events. The patient was advised by her doctor to not receive the second Moderna vaccine.  On 05 Mar 2021, the patient was seen by and ENT (Ear, Nose & Throat) doctor. It was recommended that the patient have a CT (computerized tomography) scan of the left side of her face and reported a swollen salivary gland.  On 01 Apr 2021, the patient was seen by an allergist for her symptoms. The allergist also advised her to have the CT scan done.  CT scan was scheduled for 27 Apr 2021 and had not been done at the time of reporting.   It was reported there were no side effects after giving the second dose to the patient.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Reporter details and patient details were updated On 02-Jul-2021: 2nd dose date, batch number, vaccination location